Operating income decreased 3.5%
Operating income changed -3.5% from the comparable as-filed period.
-$6.2M→-$6.4M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →APVO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development increased 11.1%
Research & development changed +11.1% from the comparable as-filed period.
$3.3M→$3.7M3 prior comparisons
Working capital / assets moved 98 bp lower
Working capital / assets changed -98 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
39.62%→38.64%4 prior comparisons
Current liabilities increased 6.1%
Current liabilities changed +6.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$4.9M→$5.2M4 prior comparisons
Working capital decreased 9.4%
Working capital changed -9.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$6.2M→$5.6M4 prior comparisons
Current ratio decreased 8.1%
Current ratio changed -8.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
2.27→2.084 prior comparisons
Total assets decreased 7.1%
Total assets changed -7.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$15.6M→$14.5M4 prior comparisons
Cash & equivalents increased 4.1%
Cash & equivalents changed +4.1% from the comparable as-filed period.
$9.4M→$9.8M3 prior comparisons
Current assets decreased 2.6%
Current assets changed -2.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$11.1M→$10.8M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.